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Chapter 3: Mechanistic studies on Lewis acid enabled 
copper-catalyzed enantioselective conjugate addition of 
Grignards to α,β-unsaturated carboxamides  
 
The presence of a strong LA together with chiral Cu(I)-catalyst and highly reactive Grignard 
reagents in the catalytic system developed in the chapter 2 makes for a complex system. 
Here, we studied the mechanism which revealed the fate of the Lewis acid in each 
elementary step of this reaction. Based on theses studies the most likely catalytic cycle for 
the copper-catalyzed asymmetric conjugate addition of Grignards to α,β-unsaturated 


















Part of this chapter has been published: 
M. Rodríguez-Fernández, X. Yan, J. F. Collados, P. B. White, S. R. Harutyunyan, J. Am. Chem. 




It is generally assumed that the mechanism of the Cu-catalyzed enantioselective CA of 
organometallic compounds follows similar principles as proposed for the non-catalytic 
organocuprate addition. The latter proceeds through reversible formation of a copper-
olefin π-complex, involving d,π* back-donation, followed by a formal oxidative addition to 
the β-carbon leading to a d8 copper(III) intermediate and, finally, reductive elimination to 
form the enolate involving an oxidative addition-reductive elimination pathway (Scheme 
1).1-16 
 
Scheme 1: proposed mechanistic pathway for the stoichiometric 1,4-addition of organocuprates. 
In 2006, Feringa et. al. performed a detailed mechanistic study of the copper-catalyzed CA 
of Grignard reagents by combining spectroscopic studies, kinetic analysis, and screening of 
reaction parameters.17 They found that there is a rapid equilibration for the chiral Cu-
catalyst to form either a mononuclear (3 and 4) or a dinuclear (1 and 2) complex, 
depending on the solvent employed (Scheme 2).18 The preparation of the bromide complex 
from CuX and ligand L (L1 or L2) using ethereal (Et2O, MTBE) or halogenated (DCM, CHCl3) 
solvents led to the dinuclear structures 1 or 2. In contrast, the mixture of CuBr and ligand L 
(L1 or L2) in CH3CN or MeOH led to the formation and precipitation of the mononuclear 
complex 3 or 4. This mononuclear Cu-complex 3 or 4 can also be prepared by dissolving 
the dinuclear complex 1 or 2 in CH3CN. In contrast to the dinuclear complex 1 or 2, the 
mononuclear complex 3 or 4 is insoluble in Et2O and MTBE. However, in halogenated 
solvents, such as DCM or CHCl3, 3 or 4 dissolves readily, yielding the dinuclear complex 1 
or 2. 
 





Keeping in mind that ACA reactions with Grignard reagents typically make use of  ethereal 
(Et2O, MTBE) or halogenated (DCM, CHCl3) solvents, the dinuclear complex (1 and 2) will 
be formed first. Upon addition of MeMgBr to the solution of the dinuclear complex, 
transmetallation occurs resulting in mononuclear complex A, accompanied by the 
formation of traces of species B (Scheme 3). In contrast, when MeLi or Me2Mg are used 
rather than Grignard reagents, species C is formed instead. 
 
Scheme 3: transmetallation of the catalyst with MeMgBr or MeLi to give rise to species A, B and C. 
The same authors also found that addition of an equimolar amount of Michael acceptor 
substrates to either species A or C led to the formation of the conjugate addition products. 
The reaction with species A proceeded with excellent conversion and enantioselectivity 
whereas with species C lower conversion and ee was observed. Taking into account that 
species C can be formed by either addition of Me2Mg to the dinuclear complex or of dioxane 
to species A, the data correlates well with the low conversion and enantioselectivity 
obtained in the catalytic reactions performed with Me2Mg and with MeMgBr in 
combination with dioxane as an additive (dioxane is commonly is used as a reagent to 
prepare R2Mg from RMgBr by binding to MgBr2). Thus, the generation of species A, rather 
than C, is essential to obtain high levels of regio- and enantioselectivity in the catalytic CA 
of Grignard reagents to α,β-unsaturated carbonyl compounds. Species B was considered a 
side product accompanying the formation of species A and C and its structure remained 
unknown until the work described in this thesis (see below).   
 




Based on speciation analysis and also kinetic studies a catalytic cycle was proposed for the 
ACA of Grignard reagents to α,β-unsaturated carbonyl compounds (Scheme 4). In this 
proposal the first step in the catalytic cycle is initiated by the transmetallation between the 
dimeric precatalyst and RMgBr to form the catalytically active complex A. Then the copper 
in complex A binds to the double bond of the substrate to form the π-complex with an 
additional interaction of Mg2+ with the oxygen atom of the carbonyl moiety. Mg2+ is 
important for the reaction because removing Mg2+ from the system leads to the formation 
of species C, thus giving the products with lower conversion and ee. The formation of a π-
complex is possibly followed by intramolecular rearrangement to a Cu(III)-intermediate 
where copper forms a σ-bond with the β-carbon of the enone (or enoate). The combination 
of Grignard reagent, diphosphine ligand, as well as the halogen still bound to the copper, 
provides donor ligands (electrons) to this formal organocopper species, that consequently 
has the reactivity and electronic properties of cuprate types of structures. In addition to 
inducing increased reactivity, these donor ligands also ensure the necessary geometry of 
the σ-complex and afford excellent regio- and stereocontrol in ACA reactions. This σ-
complex is in fast equilibrium with the π-complex, and the equilibrium constant between 
both complexes depends on the stability of the Cu(III)-intermediate. This fast equilibrium 
can cause the isomerization of the substrate from the cis-configuration to the more stable 
trans-configuration. The final step is the rate-limiting, reductive elimination step to 
generate the product enolate and recover the catalytically active complex A. The results 
demonstrate that the rate of the reaction depends on all the reacting components, and is 
first order in the catalyst and second order in the Grignard reagent. 
In principle, the mechanism of LA enabled Cu-catalyzed ACA of Grignards to α,β-
unsaturated carboxamides  should be similar to the Cu-catalyzed ACA of Grignard reagents 
to α,β-unsaturated carbonyl compounds. However, the necessary presence of LA to 
accomplish enantioselective CA to α,β-unsaturated carboxamides adds another level of 
mechanistic complexity. LA additives have been known for decades to accelerate the CA of 
organometallics to various α,β-unsaturated carbonyl derivatives.19 In particular, the use of 
very weak TMSCl became common practice in CA of various hard organometallics.19-25 In 
contrast, relatively strong LAs, such as BF3·Et2O, have been used only in CA of 
stoichiometric organocopper reagents.19,26-28 In our case, the presence of a strong LA 
together with only few percent of chiral Cu(I)-catalyst and highly reactive Grignard 
reagents makes for a complex system. Therefore, we performed mechanistic study to gain a 
deeper understanding on the role of LA in our catalytic system. 
3.2 Results and discussions 
The outcome of the reaction depends critically not only on the relative rates of the desired 
catalyzed and the undesired non-catalyzed pathways but also on those of several 
competing processes (Scheme 5). We proposed a new catalytic cycle for Cu-catalyzed ACA 
of Grignards to α,β-unsaturated carboxamides involving LA based on the mechanistic 
studies (Scheme 6). We expect the catalytic cycle to be initiated by the formation of species 






Scheme 5: undesired reaction pathways in the CA of Grignard reagents to α,β-unsaturated carboxamides  in 
the presence of LA followed by 1H NMR spectroscopy in CD2Cl2 at −80 °C. 
 
Scheme 6: proposed catalytic cycle for the LA enabled ACA addition of Grignard reagents to carboxamide. 
We prepared species 6 by addition of MeMgBr to chiral catalyst 1 and analyzed it by 1H and 
31P NMR spectroscopy. A 3.0 M MeMgBr solution in Et2O (20 μL, 0.06 mmol) was added to a 
solution of catalyst 1 (11 mg, 0.015 mmol) in CD2Cl2 (0.6 mL) in a dry NMR tube at −78 °C 
and the resulting mixture was immediately measured by 1H and 31P NMR spectroscopy at 
−80 °C. Two different transmetallated complexes A and B (species 6) were detected as 
expected (Figures 1 and 2). Both species present methyl moieties coupled with both 
phosphines with the same pattern in the 1H-31P HMBC spectrum (Figure 3). Species A and B 
conform to the previously reported species A and B (Scheme 3) in the mechanistic study on 
the CA addition of Grignard Reagents to α,β-unsaturated carbonyl compounds.17 We have 
redefined the structure of species 6 based on these data: species B: −0.28 ppm, dd, CuMe in 
1H NMR; 14.8 (d, J = 155.5 Hz), −18.0 (d, J = 155.5 Hz) in 31P NMR and species A: −0.37 ppm, 
dd, CuMe in 1H NMR; 7.5 (d, J = 144.3 Hz), −26.4 (d, J = 144.3 Hz) in 31P NMR. For both 
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species the integration indicates that only one methyl group is bound to the copper (based 
on the 1:1 ratio measured by comparison of the Me signal with signals from the ferrocene). 
For these reasons both species A and B are assumed to be the two possible 
diastereoisomers of the transmetallated species 6. One can imagine that transmetallation 
of enantiopure chiral Cu-complex 1 proceeds with the formation of two diastereoisomers 
(orientation of the Me group with respect to the ferrocenyl ligand in the Cu-bound 
complex) where species A is the major and species B the minor one. The catalytic activity 
of species A and B is identical as well.  
 
Figure 1: 1H NMR spectrum of the transmetallated species 6. 
 






Figure 3: 1H-31P HMBC spectrum of the transmetallated species 6. Similar pattern of coupling with the 
phosphines is observed for both species. 
However, the chiral ligand L1, reversibly bound to copper, is Lewis basic, and thus a strong 
LA competes with copper for binding to L1, potentially destroying the chiral catalyst 1 
(Scheme 5). This was confirmed by a control experiment that saw the formation of a 
mixture of unidentified species lacking bidentate coordination to copper (singlets versus 
doublets in 31P NMR) upon addition of either LA to chiral copper complex L1-CuBr (Figure 
4). Remarkably though, addition of MeMgBr to this mixture resulted in an immediate 
recovery of either the L1-CuBr or the transmetallated copper complex 6, depending on the 
remaining amount of Grignard reagent in the media. Similarly, adding an excess of LA to the 
transmetallated copper complex did not affect its structure. Even when adding copper salt 
and Grignard after combining LA with L1, species 6 is formed, demonstrating its 
remarkable formation rate and stability. 
This can be proved by a set of experiments we carried out. Complex L1-CuBr (5.9 mg, 0.08 
mmol)  was dissolved in CD2Cl2 (0.6 mL) in a dry NMR tube under a N2 atmosphere and 
cooled down to −78 °C. TMSOTf (15 μL, 0.08 mmol) or BF3·Et2O (10 μL, 0.08 mmol) were 
added to the complex and the resulting mixture was analyzed by 1H and 31P NMR 
spectroscopy at −60 °C. Complex L1-CuBr  (doublets, Figure 4b) disappeared in both cases 
and unidentified phosphorus containing species were formed: singlets at 27.1 and 4.4 ppm; 
with TMSOTf (Figure 4c) , and singlets at 31.9, 0.5 and −0.3 ppm; with BF3·Et2O (Figure 4d). 
Observing phosphorus signals as singlets instead of the initial doublets indicates 
detachment of, at least, one of the phosphine moieties of the complex L1-CuBr. Formation 
of new L1-CuBr complex with monodentate instead of bidentate coordination cannot be 
excluded either. After cooling down again to −78 °C, a 3 M MeMgBr solution in Et2O (67 μL, 
0.2 mmol) was added and the mixture was analyzed by 1H and 31P NMR spectroscopy at 
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−60 °C. Importantly the transmetallated L1-CuBr species 6 was observed in both cases, 
although in the case of TMSOTf only isomer A (Figure 4e) and in the case of BF3·Et2O only 
isomer B among other signals (Figure 4f). Similarly, the addition of TMSOTf or BF3·Et2O to 
the transmetallated species 6 (Figure 4b) does not change the structure of the complex and 
the same NMR spectra were obtained (not depicted). 
 
Figure 4: 31P NMR spectra of combinations of L1-CuBr, MeMgBr and LA. Left column: from top to bottom the 
panels show the spectra of (a) the L1-CuBr complex, (b) the transmetallated species 6 (with A and B 
diastereoisomers), (c) L1-CuBr after adding 10 equiv. of TMSOTf, (e) the result of adding 10 equiv. of MeMgBr 
to (c) leading to the formation of species A. Right column: same as left column, but using BF3·Et2O instead of 
TMSOTf. (a) the L1-CuBr complex, (b) the transmetallated species 5 (with A and B diastereoisomers), (d) L1-
CuBr after adding 10 equiv. of BF3·Et2O, (f) the result of adding 10 equiv. of MeMgBr to (d) leading to the 
formation of species A and L1-CuBr together with decomposed complex peaks from (d). 
Apart from the undesired reaction between the LA and the L1-CuBr complex another 
potential problem in this catalytic system is the reaction between the LA and the Grignard 
reagent: transmetallation of the LA by the Grignard reagent can deplete both components, 
as was confirmed by NMR spectroscopy. An equimolar mixture of MeMgBr solution in Et2O 
(33 μL, 0.1 mmol) and BF3·Et2O (12 μL, 0.1 mmol) in CD2Cl2 (0.6 mL) was prepared in a dry 
NMR tube under N2 atmosphere at −78 °C and measured by NMR spectroscopy at −80 °C. 
Formation of Me4BMgBr (−0.74 ppm, q, J = 3.7 Hz in 1H NMR, −19.8 ppm, m, J = 3.7 Hz in 11B 
NMR) was immediately detected at −80 °C (Figures 5 and 6). Likewise, formation of Me4Si 
(−0.08 ppm in 1H NMR, Figure 7) was detected by 1H NMR at −60 °C when MeMgBr 
(solution 3 M in Et2O, 33 μL, 0.1 mmol) was added to a solution containing TMSOTf (18 μL, 
0.1 mmol) in CD2Cl2 (0.6 mL).  
Thus, NMR guided control experiments confirmed that in the absence of unsaturated 
carboxamide substrate or L1-CuBr complex, all pathways indicated in Scheme 5 can occur. 
Fortunately, the excellent results observed for our system constitute evidence that all these 






Figure 5: 1H NMR spectrum of the equimolar mixture of MeMgBr and BF3·Et2O in CD2Cl2. 
 




Figure 7: 1H NMR spectrum of TMSOTf (top) and the equimolar mixture of MeMgBr and TMSOTf in CD2Cl2 
(bottom). Appearance of a new peak of Me4Si was immediately detected (highlighted). 
 







Figure 9: 1H-1H-ROESY spectrum of the equimolar mixture of carboxamide 7 and TMSOTf and expansion. 
Cross-peaks between the TMS moiety and both Hb (blue) and one of the NMe groups (orange) and between 




Figure 10: 1H-13C-HSQCED spectrum of the equimolar mixture of carboxamide 7 and TMSOTf. TMS-
carboxamide complex cross-peaks are highlighted. 
 
Figure 11: 1H-13C-HMBC spectrum of the equimolar mixture of carboxamide 7 and TMSOTf. TMS-






Figure 12: 1H-29Si-HMBC spectrum of the equimolar mixture of carboxamide 7 and TMSOTf. TMS-
carboxamide complex cross-peaks are highlighted. 
According to our proposed catalytic cycle depicted in Scheme 6, the formation of 
transmetallated copper complex 6 is followed by the π-complexation with potentially 
activated carboxamide 8 or 9 to form species 10 or 10’, followed by the formation of σ-
complex intermediates 12 or 12’ (silyl enolate in case of TMSOTf and boron enolate in case 
of BF3·Et2O). We initially anticipated the activated carboxamide to be LA-carboxamide 
complex 8, the formation of which was indeed observed by 1H NMR spectroscopy when 
adding either BF3·Et2O or TMSOTf to a solution of carboxamide in CD2Cl2. TMSOTf (16 μL, 
0.088 mmol) was added to a solution of 7 (10 mg, 0.088 mmol) in CD2Cl2 (0.6 mL) in a dry 
NMR tube at −78 °C under N2 atmosphere, leading to instantaneous formation of a new 
species, detected using NMR spectroscopy at −80 °C. Two carboxamide complexes were 
observed and characterized as TMS-carboxamide complex (assigned in Figure 8) and 
protonated carboxamide. Water derived from the carboxamide substrates partially 
hydrolizes TMSOTf resulting in the formation of TfOH, which can protonate the 
carboxamide as well. The formation of an iminium-type complex, placing the silyl moiety 
on the oxygen atom, was suggested by the deshielded NMe2 groups in the new iminium 
moiety (up to 0.5 ppm downfield) and confirmed by a 1H-1H ROESY experiment (Figure 9). 
NMR spectroscopy also confirmed s-trans conformation. Full characterization was carried 






Figure 13: 1H NMR spectrum of the equimolar mixture of carboxamide 7 and BF3·Et2O. 
 
Figure 14: 1H-19F-HOESY spectrum of the equimolar mixture of carboxamide 7 and BF3·Et2O. Cross-peak with 
the carboxamide moieties (green) and 19F signal at −147 ppm confirmed the formation of a complex. BF3-






Figure 15: 11B-NMR spectrum of the equimolar mixture of carboxamide 7 and BF3·Et2O. 
 




Figure 17: 1H-13C-HSQCED spectrum of the equimolar mixture of carboxamide 7 and BF3·Et2O. BF3-
carboxamide complex cross-peaks are highlighted. 
 
Figure 18: 1H-13C-HMBC spectrum of the equimolar mixture of carboxamide 7 and BF3·Et2O. BF3-
carboxamide complex cross-peaks are highlighted. 
Similarly, BF3·Et2O (10 μL, 0.08 mmol) was added to a solution of carboxamide 7 (9 mg, 
0.08 mmol) in CD2Cl2 (0.6 mL) in a dry NMR tube at −78 °C. Instantaneous formation of a 
new species at −80 °C was measured by NMR spectroscopy. In analogy with the experiment 





few other acidic proton peaks were detected as well due to the water present in the 
substrate. Formation of a carboxamide-BF3 complex was confirmed by 1H-19F-HOESY 
spectra (Figure 14) and fully characterized by 11B-NMR (Figure 15), 19F-NMR (Figure 16), 
1H-13C-HSQCED (Figure 17), and 1H-13C-HMBC (Figure 18). 
 
Figure 19: 1H NMR spectra of LA-carboxamide complexes: free carboxamide (brown), with TMSOTf (orange), 
BF3·Et2O (purple), with MeMgBr (blue), the reaction media before completion (green). 
 




Figure 21: 1H NMR spectrum of the reaction media in the reaction of carboxamide 7 with MeMgBr in the 
presence of L1-CuBr complex and TMSOTf in CD2Cl2. 
While these experiments with carboxamide 7 and LAs confirmed the formation of activated 
carboxamide species 8 (catalytic cycle in  scheme 6), surprisingly, the subsequent addition 
of a stoichiometric amount of MeMgBr led to the formation of a new species corresponding 
to MeMgBr-carboxamide complex 9 (Figure 19). First we prepared complex 9 for 
comparison. A 3.0 M MeMgBr solution in Et2O (54 μL, 0.2 mmol) was added to a solution of 
amide 7 (6 mg, 0.05 mmol) in CD2Cl2 (0.6 mL) in a dry NMR tube at −78 °C. Instantaneous 
formation of a new species at −80 °C attributed to MeMgBr/carboxamide complex was 
measured by NMR spectroscopy (Figure 20). Only this species was observed in this 
experiment. Then a set of reactions was carried out in the presence of TMSOTf or BF3·Et2O 
in CD2Cl2 either directly in the NMR tubes or in dry Schlenk flasks at −78 °C and then 
measured at −80 °C (Figure 21, only the reaction media in the presence of TMSOTf are 
shown). In a flame-dried Schlenk tube equipped with septum and magnetic stirring bar, 
CuBr-(R,SFe)-L1 complex (5.53 mg, 0.0075 mmol, 5 mol%) and amide 7 (17 mg, 0.15 mmol) 
were dissolved in CD2Cl2 (1.5 mL) and stirred under nitrogen atmosphere. After stirring at 
room temperature for 5 minutes, the reaction mixture was cooled to −60 °C and TMSOTf 
(52 μL, 0.30 mmol) was added. After 15 minutes, MeMgBr (100 μL, 0.30 mmol, 3.0 M in 
Et2O) was added. Then the mixture was transferred to a NMR tube cooled to −78 °C and 
then measured by NMR spectroscopy at −80 °C. Regardless of the LA used, the only species 
observed in the reaction media corresponded to the complex 9 derived from the 
interaction between the carboxamide and MeMgBr (Figure 19). The same complex 9 was 
also detected when MeMgBr was added to the preformed TMSOTf-carboxamide or 
BF3·Et2O carboxamide complexes preformed in the absence of other reaction 
intermediates. These results suggest that MeMgBr replaces the Lewis acid and forms a 





On the one hand it seems reasonable to assume (catalytic cycle in Scheme 6) that π-
complexation of species 6 with the relatively more stable activated carboxamide 9 would 
occur next, forming π-complex 10 in step 1. On the other hand, based on the 
Curtin−Hammett principle, direct formation of π-complex 10’ in step 2’ cannot be excluded. 
Thus, the main question is at which stage the LA is involved in the catalytic cycle: before, 
during, or after oxidative addition step or during or after reductive elimination step. To 
answer this question further experiments were performed. 
Table 1: effect of different LAs in the Cu-catalyzed CA of EtMgBr to 13a 
 
Entry LA Yield [%]b ee [%]c 
1 TMSCl <7 nd 
2 TMSBr 44 78 
3 BF3·Et2O 73 97 
4 TMSOTf 92 92 
5 TBSOTf 91 91 
6 TBDPSOTf 84 88 
aReaction conditions: 0.1 M of 13 in DCM, CuBr·SMe2 (5 mol%), ligand L1 (6 mol%), LA (2.0 equiv.), EtMgBr 
(2.0 equiv.), −78 °C, 18 h. bYield of isolated 14. cEnantiomeric excess was determined by HPLC on a chiral 
stationary phase.  
Based on the E−Z isomerizations of α,β-unsaturated carbonyl substrates often observed in 
copper-catalyzed CA reactions and specific isotope effects observed, the oxidative addition 
step is thought to be reversible, with the rate enhancement upon addition of TMSCl 
attributed to making the oxidative step irreversible.19-25 To verify whether this holds true 
for the role of BF3·Et2O and TMSOTf in our reaction, more experiments were executed. A 
number of different LAs were tested varying in strength and sterics (Table 1). The results 
reveal clearly that the strength of the LA is crucial for our catalytic cycle, with the very 
weak TMSCl producing <7% conversion, the relatively stronger TMSBr a poor 44%, and the 
stronger TMS-, TBS- and TBDPS- substituted triflates as well as BF3·Et2O providing 
excellent results, both in terms of reactivity and selectivity. Furthermore, the nearly 
identical ees given by the three sterically varying triflates imply that the LA does not affect 
the enantiodiscrimination step. The differences observed in the ee using various LA are 
explained by different rates between the enantioselective Cu-catalyzed and the non-
catalyzed racemic CA reactions. 
Double-bond isomerization of the carboxamide substrate ((Z)-13 to the more stable (E)-
13) was studied as well (Table 2). Copper-catalyzed CA of MeMgBr or EtMgBr to (Z)-13 led 
to the final products with absolute configuration opposite to that obtained with (E)-13 
when using BF3·Et2O and TMSOTf at −78 °C, respectively. No isomerization product to the 
more stable (E)-13 was obtained using TMSOTf (Table 2, entries 3, 9, 11, 13, 16 and 20) or 
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with a little conversion up to 2.5% in the presence of BF3·Et2O (Table 2, entries 2, 8, 10, 12, 
14 and 18). This is consistent with the interpretation that step 2 (or 3’) of the catalytic 
cycle is not reversible. 
Table 2: Cu-catalyzed CA of MeMgBr or EtMgBr to (E)- or (Z)-13a 
 
Entry 13 L1/Cu [mol%] LA RMgBr 
(Z):(E):14b 
(Z):(E):15b 
ee [%]c Conf. of 14 or 15 
1 Z 5 − − 100:0:− − − 
2 Z − BF3·Et2O − 100:0:− − − 
3 Z − TMSOTf − 100:0:− − − 
4 Z − − MeMgBr 100:0:0 − − 
5 Z − − EtMgBr 100:0:0 − − 
6 Z 5 − MeMgBr 100:0:0 − − 
7 Z 5 − EtMgBr 100:0:0 − − 
8 Z − BF3·Et2O MeMgBr 100:0:0 − − 
9 Z − TMSOTf MeMgBr 100:0:0 − − 
10 Z − BF3·Et2O EtMgBr 100:0:0 − − 
11 Z − TMSOTf EtMgBr 98:0:2 − − 
12 Z 5 BF3·Et2O − 95.5:2.5:− − − 
13 Z 5 TMSOTf − 100:0:− − − 
14 Z 5 BF3·Et2O MeMgBr 75.8:1.6:22.6 99 (S)-15 
15 Ed 5 BF3·Et2O MeMgBr −:35:65 99 (R)-15 
16 Z 5 TMSOTf MeMgBr 93:0:7 46 (S)-15 
17 Ed 5 TMSOTf MeMgBr −:8:92 99 (R)-15 
18 Z 5 BF3·Et2O EtMgBr 37.4:1.6:61 96 (S)-14 
19 Ed 5 BF3·Et2O EtMgBr −:6:94 97 (R)-14 
20 Z 5 TMSOTf EtMgBr 70:0:30 33 (S)-14 
21 Ed 5 TMSOTf EtMgBr −:6:94 92 (R)-14 
aReaction conditions: 0.16 mmol of (Z)-13 in 1.6 mL of DCM, CuBr·SMe2 (5 mol%), ligand L1 (6 mol%), LA 
(2.0 equiv.), RMgBr (2.0 equiv.), −78 °C, 18 h. bThe ratio between (Z)-13:(E)-13:14 or (Z)-13:(E)-13:15 was 
determined by 1H-NMR. cEnantiomeric excess was determined by HPLC on a chiral stationary phase. d0.2 
mmol of (E)-13 were used in this case. 
Combining the results on the strength of the LA, its lack of effect on the 
enantiodiscrimination, the lack of isomerization and Cu-catalyzed ACA in the absence of LA, 
and all the discussed experimental data, we believe that the LA is almost certainly involved 
in one of the steps preceding reductive elimination (step 4), making the oxidative addition 
overall irreversible (catalytic cycle , Scheme 6). Strong LA is either required to increase the 
π-acidity of the π-complex (as in π-complex 10’ formed in step 2’) or to trap the 
magnesium enolate σ-complex 11 into the more stable silyl or boron enolate σ-complex 11’ 
(step 3). In both scenarios, that cannot be distinguished with the current data, the resulting 
more stable silyl or boron enolate σ-complex 11’ is expected to undergo faster reductive 





of σ-complex 11’ comes from the fact that only Mg activated carboxamide 9 and silyl or 
boron enolates of the CA addition products (Figure 22) are observed, with no traces of 8 or 
Mg-enolate of the CA-product throughout the reaction. For the experiments confirming the 
structure of the CA-enolate products see the following discussion.  
 
Figure 22: Types of enolates formed as end product of the CA of MeMgBr to carboxamide in the reaction 
using TMSOTf (blue), BF3·Et2O (green), and in the absence of LA (brown) determined by TOCSYs experiments. 
 




Figure 24: TOCSY experiment (irradiating nucleus Ha) of the crude of the reaction in the presence of TMSOTf. 
 
Figure 25: 1D ROESY experiments of the crude of the reaction in the presence of TMSOTf. Z-enolate 
configuration was determined by observation of NOE between the TMS moiety and Hb (orange) and between 






Figure 26: 1H-13C-HSQCED spectrum of the crude of the reaction in the presence of TMSOTf. TMS-enolate 
peaks are highlighted. 
 





Figure 28: 1H-29Si-HMBC spectrum of the crude of the reaction in the presence of TMSOTf. TMS-enolate peaks 
are highlighted. 
The structure of the final product of the reaction, namely the enolates, was determined by 
analysis of the reaction crude before quench in CD2Cl2. First we performed the catalytic 
ACA in the presence of TMSOTf, aiming at the formation of the silyl enolate. In a flame-
dried Schlenk tube equipped with septum and  magnetic stirring bar, CuBr-(R,SFe)-L1 
complex (5.53 mg, 0.0075 mmol, 5 mol%) and amide 7 (17 mg, 0.15 mmol) were dissolved 
in CD2Cl2 (1.5 mL) and stirred under nitrogen atmosphere. After stirring at room 
temperature for 5 min., the reaction mixture was cooled to −60 °C and TMSOTf (52 μL, 0.30 
mmol) was added. After 15 min., MeMgBr (100 μL, 0.30 mmol, 3.0 M in Et2O) was added. 
After stirring at −60 °C for 18 h, the mixture was transferred to a NMR tube followed by 
measurement at −80 °C. The final product in the reaction mixture was identified as a TMS-
enolate (Figure 23), based on a TOCSY experiment (Figure 24). (Z)-configuration was 
assigned to the enolate, based on series of 1D ROESY experiments (Figure 25). Full 
characterization by 1H-13CHSQCED (Figure 26), 1H-13C-HMBC (Figure 27) and 1H-29Si-
HMBC (figure 28) was carried out. 
Then we performed the catalytic ACA in the presence of BF3·Et2O to form the boron 
enolate. In a flame-dried Schlenk tube equipped with septum and magnetic stirring bar, 
CuBr-(R,SFe)-L1 complex (5.53 mg, 0.0075 mmol, 5 mol%) and amide 7 (17 mg, 0.15 mmol) 
were dissolved in CD2Cl2 (1.5 mL) and stirred under nitrogen atmosphere. After stirring at 
room temperature for 5 min., the reaction mixture was cooled to −60 °C and BF3·Et2O (37 
μL, 0.30 mmol) was added. After 15 min., MeMgBr (100 μL, 0.30 mmol, 3.0 M in Et2O) was 
added. After stirring at −60 °C for 18 h, the mixture was transferred to a NMR tube, cooled 
and measured by NMR spectroscopy at −80 °C. A BF3-enolate structure was assigned based 





experiment (Figure 30) Ha, Hb, Hc protons were assigned. Full characterization of the 
enolate was done by 1H-13C-HSQCED (Figure 31) and 1H-13C-HMBC (Figure 32) 
experiments. 
 
Figure 29: 1H NMR spectrum of the crude of the reaction in the presence of BF3·Et2O. 
 





Figure 31: 1H-13C-HSQCED spectrum of the crude of the reaction in the presence of BF3·Et2O. BF3-enolate 
peaks are highlighted. 
 
Figure 32: 1H-13C-HMBC spectrum of the crude of the reaction in the presence of BF3·Et2O. BF3-enolate peaks 
are highlighted. 
However, the configuration of the enolate could not be determined by HOESY experiments 
since no clear cross-peak 1H-19F was observed. To prove that the enolate we observed in 
this case is not a magnesium enolate we prepared Mg-enolate independently for 





MeMgBr solution in Et2O (67 μL, 0.2 mmol) was added to a solution of amide 1a (12 mg, 
0.10 mmol) in CD2Cl2 (0.6 mL) in a dry NMR tube under N2 atmosphere. After 18 h the 
mixture was measured by NMR spectroscopy at −80 °C. A Mg-enolate structure was 
assigned based on 1H NMR (Figure 33). Enolate proton (Ha) was detected in the crude and 
a TOCSY experiment (Figure 34) was carried out to assign the spin system (Ha, Hb, Hc). Full 
characterization by 1H-13C-HSQCED (Figure 35) and 1H-13CHMBC (Figure 36) was carried 
out. 
 




Figure 34: TOCSY experiment (irradiating nucleus Ha) of the crude of the reaction in the absence of Lewis 
acid. 
 
Figure 35: 1H-13C-HSQCED spectrum of the crude of the reaction in the absence of Lewis acid. Mg-enolate 
peaks are highlighted. 
 






This set of experiments shows that three different enolates, namely TMS-enolate (in the 
presence of TMSOTf), BF3-enolate (in the presence of BF3·Et2O) and Mg-enolate (in the 
absence of Lewis acid) are formed in the reaction mixture, depending on the reaction 
components (Figures 22−36). 
3.3 Conclusions 
Our mechanistic studies identified the structure of various species involved in the LA-
enabled, Cu-catalyzed ACA of Grignards to α,β-unsaturated carboxamides and support the 
notion that the role of the LA is in the enhancement of the copper-catalyzed pathway. As a 
result, LA allows both the ACA to occur as well as to outcompete the blank reactions that 
occur at higher temperatures. Furthermore, the experimental data point to a very similar 
mechanistic behavior for both LAs employed in this ACA of Grignard reagents to α,β-
unsaturated carboxamides, namely BF3·Et2O and TMSOTf. The unexpected compatibility 
observed in our catalytic system between highly reactive Grignard reagents, LAs, and 
phosphine ligands was found to be due to the remarkable stability of the active catalyst 
toward the deleterious effect of LAs. 
3.4 Experimental section 
3.4.1 General experimental information 
All reactions using oxygen- and/or moisture-sensitive materials were carried out with 
anhydrous solvents (vide infra) under a nitrogen atmosphere using oven-dried glassware 
and standard Schlenk techniques. Flash column chromatography was performed using 
Merck 60 Å 230−400 mesh silica gel. Thin layer chromatography was performed using 0.25 
mm E. Merck silica plates (60F-254). Unless otherwise indicated, the products were 
visualized by UV and KMnO4 staining. NMR data was collected on Varian VXR400 (1H at 
400.0 MHz; 13C at 100.58 MHz) equipped with a 5 mm z-gradient broadband probe. 
Chemical shifts are reported in parts per million (ppm) relative to residual solvent peak 
(CDCl3, 1H: 7.26 ppm; 13C: 77.16 ppm; CD2Cl2, 1H: 5.32 ppm; 13C: 53.84 ppm). Coupling 
constants are reported in Hertz. Multiplicity is reported with the usual abbreviations (s: 
singlet, d: doublet, t: triplet, q: quartet, m: multiplet). Variable-temperature NMR spectra 
were acquired on a Bruker Avance III spectrometer paired with an Ascend 400 MHz 
magnet and BBFO dual-resonance probe. All temperatures were calibrated prior to 
acquisition with an external pure MeOH reference. 1H TOCSY and ROESY experiments were 
carried out with 9.6 kHz and 4.54 kHz spinlocking fields, and the ROESY mix time was set 
to 400 ms. 1H-19F HOESY experiments utilized a mix time of 350 ms. 1H-13C HSQCED spectra 
were recorded with the 1JCH constant set to 145 Hz while the 1H-13C and 1H-29Si HMBC 
spectra were recorded with a nJXH constant set to 8 Hz and 10 Hz, respectively. 1D 19F 
spectra were acquired with inverse-gated 1H decoupling. 1D 31P spectra were acquired 
with 1H decoupling during the relaxation delay and acquisition time and thus are non-
quantitative. Exact mass spectra were recorded on a LTQ Orbitrap XL apparatus with ESI 
ionization. Enantiomeric excess were determined by chiral HPLC analysis using a Shimadzu 




Unless otherwise indicated, reagents and substrates were purchased from commercial 
sources and used as received. Dry solvents were freshly collected from a dry solvent 
purification system prior to use. Inert atmosphere experiments were performed with 
standard Schlenk techniques with dried P2O5 nitrogen gas. Grignard reagents were 
purchased from Sigma-Aldrich: EtMgBr, MeMgBr (2.0 M in Et2O). All Grignard reagents 
were titrated by 1H NMR before use. Unless otherwise noted α,β-unsaturated carboxamides  
substrates were prepared following the literature methods (vide infra). Chiral ligand L1 
were purchased from Sigma Aldrich and Solvias. All reported compounds were 
characterized by 1H NMR and compared with literature data. All new compounds were fully 
characterized by 1H and 13C NMR and HRMS techniques. 
3.4.3 Determination of absolute configuration 
The absolute configuration of 14 and 15 was assigned by analogy to 2a and 3h in chapter 
2. 
3.4.4 Procedures and characterization of products 
(E)-N,N-Dimethylbut-2-carboxamide (7)29 
 
A solution of acyl chloride (0.96 mL, 10 mmol) in 6.3 mL dry Et2O was cooled to 0 °C in an 
ice-bath. Anhydrous dimethylamine (2.0 M in THF, 10 mL, 20 mmol) was added for over 5 
min and the reaction mixture was allowed to warm to room temperature (12 h). The 
solvents were evaporated under reduced pressure. Product 7 was obtained as a colorless 
liquid after column chromatography (SiO2, Et2O) in 90 % yield. 1H NMR (CDCl3, 400 MHz): δ 
6.87 (dq, J = 15.0, 6.9 Hz, 1H, CH=CH), 6.27 (dq, J = 15.0, 1.7 Hz, 1H, CH=CH), 3.06 (s, 3H, 
NCH3), 2.99 (s, 3H, NCH3), 1.87 (dd, J = 6.9, 1.7 Hz, 3H, CH3CH). 
(E)-N,N-Dimethylhex-2-enamide ((E)-13)29 
 
To a cold 0 °C solution of (E)-hex-2-enoic acid (570.7 mg, 5 mmol) in DCM (4 mL) was 
added thionyl chloride (438 μL, 6 mmol) and dry DMF (14 μL). The solution was then 
stirred at room temperature for 2 h and concentrated under reduced pressure to remove 
residual thionyl chloride. The resulting residue was redissolved in DCM (4 mL), cooled at 0 
°C and dimethylamine (2.0 M in THF, 4 mL, 8 mmol) was added. Dry triethylamine (6.6 
mmol) was added and stirring was continued at ambient temperature (3 h). The solvent 
was removed under reduced pressure and DCM (14 mL) was added. The organic phase was 
washed with dilute hydrochloric acid (2.0 M, 2 mL × 2), water (3 mL × 2), and brine (4 mL), 





colorless oil in 86% yield. 1H NMR (CDCl3, 400 MHz): δ 6.86 (dt, J = 15.1, 7.0 Hz, 1H, 
CH=CH), 6.24 (dt, J = 15.1, 1.3 Hz, 1H, CH=CH), 3.07 (s, 3H, NCH3), 2.99 (s, 3H, NCH3), 2.23-
2.14 (m, 2H, CH2CH), 1.54-1.43 (m, 2H, CH2CH3), 0.93 (t, J = 7.4 Hz, 3H, CH2CH3). 
(Z)-N,N-Dimethylhex-2-enamide ((Z)-13) 
 
To a solution of N,N-dimethylacetamide (465 μL, 5 mmol) in dry THF (15 mL) cooled to 
−78 °C, a 1.0 M solution of LDA in THF (4.5 mmol, 4.5 mL) was slowly added and the 
mixture was stirred for 30 minutes at −78 °C. Then, TMSCl (571 μL, 4.5 mmol) was added 
and the mixture was stirred for 1 h at 0 °C and, afterwards, cooled down again to −78 °C. A 
1.0 M solution of LDA in THF (4.5 mmol, 4.5 mL) was slowly added and the reaction 
mixture was stirred for 30 minutes at −78 °C. Finally, butyraldehyde (405 μL, 4.5 mmol) 
was added and the mixture was stirred overnight at −78 °C. The reaction was quenched by 
addition of MeOH (1.0 mL) and 1.0 M HCl aqueous solution (10 mL), stirred at room 
temperature for 45 minutes and extracted with Et2O (15 mL × 3). The combined organic 
layers were dried over MgSO4 and concentrated under reduced pressure. The crude 
product was purified by column chromatography on silica gel (SiO2, pentane:Et2O = 1:1) to 
afford product (Z)-13 as a colorless oil [39% yield]. 1H NMR (CDCl3, 400 MHz): δ 5.95 (dt, J 
= 11.7, 1.3 Hz, 1H, CH=CH), 5.89 (dt, J = 11.7, 7.3 Hz, 1H, CH=CH), 3.00 (s, 6H, N(CH3)2), 
2.35-2.27 (m, 2H, CH2CH=CH), 1.49-1.39 (m, 2H, CH2CH2CH3), 0.92 (t, J = 7.3 Hz, 
3H,CH2CH3). 13C NMR (CDCl3, 100 MHz): δ 168.0, 141.0, 122.0, 37.6, 35.1, 31.3, 22.3, 13.8. 
(R)-N,N-Dimethyl-3-ethyl-hexanamide ((R)-14) 
 
In a flame-dried Schlenk tube equipped with septum and magnetic stirring bar, CuBr·SMe2 
(2.06 mg, 0.01 mmol, 5 mol%) and ligand (R,SFe)-L1 (7.68 mg, 0.012 mmol, 6 mol%) were 
dissolved in 2.0 mL DCM and stirred under nitrogen atmosphere for 20 min. The substrate 
(E)-13 (0.2 mmol) was added at once. After stirring for 5 min. at RT the reaction mixture 
was cooled down to −78 °C, followed by addition of BF3·Et2O (50 μL, 0.4 mmol) or TMSOTf 
(72 μL, 0.4 mmol). After 20 min., EtMgBr was added by hand in about 1 min. After stirring 
for 18 h, the reaction was quenched with MeOH followed by addition of saturated aqueous 
NH4Cl solution and warming up to RT. The reaction mixture was extracted with DCM (10 
mL × 3). Combined organic phases were dried over MgSO4, filtered and solvents were 
evaporated on a rotary evaporator. Product (R)-14 was obtained as a colorless oil after 
column chromatography (SiO2, pentane:Et2O = 1:1). 1H NMR (CDCl3, 400 MHz): δ 3.00 (s, 
3H, NCH3), 2.93 (s, 3H, NCH3), 2.21 (dd, J = 15.1, 7.1 Hz, 1H, CHHCO), 2.20 (dd, J = 15.1, 6.7 
Hz, 1H, CHHCO), 1.91-1.81 (m, 1H, CHCH2), 1.36-1.21 (m, 5H, CH2CH3, CH2CH2CH3), 1.24-
1.18 (m, 1H, CHHCH3), 0.87 (d, J = 7.0 Hz, 3H, CH3CH), 0.85 (t, J = 7.5 Hz, 3H, CH3CH2). 13C 
98 
 
NMR (CDCl3, 100 MHz): δ 173.1, 37.8, 37.6, 36.1, 35.9, 35.5, 26.4, 19.9, 14.5, 11.0. HRMS 
(ESI+, m/Z): calcd. for C10H22NO [M+H]+: 172.1696, found: 172.1696. HPLC: Chiracel-OBH, 
n-heptane/i-PrOH 95:5, 0.5 mL/min, 40 °C, detection at 210 nm. Retention time (min): 10.4 
(minor) and 11.5 (major). 
(S)-N,N-Dimethyl-3-ethyl-hexanamide ((S)-14) 
 
In a flame-dried Schlenk tube equipped with septum and magnetic stirring bar, CuBr·SMe2 
(1.64 mg, 0.008 mmol, 5 mol%) and ligand (R,SFe)-L1 (6.15 mg, 0.0096 mmol, 6 mol%) 
were dissolved in 1.6 mL DCM and stirred under nitrogen atmosphere for 20 min. The 
substrate (Z)-13 (0.16 mmol) was added at once. After stirring for 5 min. at RT the reaction 
mixture was cooled down to −78 °C, followed by addition of BF3·Et2O (40 μL, 0.32 mmol) or 
TMSOTf (58 μL, 0.32 mmol). After 20 min., EtMgBr was added by hand in about 1 min. After 
stirring for 18 h, the reaction was quenched with MeOH followed by addition of saturated 
aqueous NH4Cl solution and warming up to RT. The reaction mixture was extracted with 
DCM (10 mL × 3). Combined organic phases were dried over MgSO4, filtered and solvents 
were evaporated on a rotary evaporator. Product (S)-14 was obtained as a colorless oil 
after column chromatography (SiO2, pentane:Et2O = 1:1). 1H NMR (CDCl3, 400 MHz): δ 3.00 
(s, 3H, NCH3), 2.93 (s, 3H, NCH3), 2.21 (dd, J = 15.1, 7.1 Hz, 1H, CHHCO), 2.20 (dd, J = 15.1, 
6.7 Hz, 1H, CHHCO), 1.91-1.81 (m, 1H, CHCH2), 1.36-1.21 (m, 5H, CH2CH3, CH2CH2CH3), 
1.24-1.18 (m, 1H, CHHCH3), 0.87 (d, J = 7.0 Hz, 3H, CH3CH), 0.85 (t, J = 7.5 Hz, 3H, CH3CH2). 
HPLC: Chiracel-OBH, n-heptane/i-PrOH 95:5, 0.5 mL/min, 40 °C, detection at 210 nm. 
Retention time (min): 10.4 (major) and 11.5 (minor). 
(R)-N,N-Dimethyl-3-methyl-hexanamide ((R)-15) 
 
In a flame-dried Schlenk tube equipped with septum and magnetic stirring bar, CuBr·SMe2 
(2.06 mg, 0.01 mmol, 5 mol%) and ligand (R,SFe)-L1 (7.68 mg, 0.012 mmol, 6 mol%) were 
dissolved in 2.0 mL DCM and stirred under nitrogen atmosphere for 20 min. The substrate 
(E)-13 (0.2 mmol) was added at once. After stirring for 5 min. at RT the reaction mixture 
was cooled down to −78 °C, followed by addition of BF3·Et2O (50 μL, 0.4 mmol) or TMSOTf 
(72 μL, 0.4 mmol). After 20 min., MeMgBr was added by hand in about 1 min. After stirring 
for 18 h, the reaction was quenched with MeOH followed by addition of saturated aqueous 
NH4Cl solution and warming up to RT. The reaction mixture was extracted with DCM (10 
mL × 3). Combined organic phases were dried over MgSO4, filtered and solvents were 
evaporated on a rotary evaporator. Product (R)-15 was obtained as a colorless oil after 
column chromatography (SiO2, pentane:Et2O = 1:1). 1H NMR (CDCl3, 400 MHz): δ 3.00 (s, 
3H, NCH3), 2.95 (s, 3H, NCH3), 2.29 (dd, J = 14.6, 5.8 Hz, 1H, CHHCO), 2.12 (dd, J = 14.6, 8.1 





1.10 (m, 1H, CHHCH2CH3), 0.93 (d, J = 6.6 Hz, 3H, CH3CH), 0.89 (t, J = 7.0 Hz, 3H, CH3CH2). 
13C NMR (CDCl3, 100 MHz): δ 172.9, 40.8, 39.5, 37.6, 35.5, 30.2, 20.3, 20.0, 14.4. HRMS 
(ESI+, m/Z): calcd. for C9H20NO [M+H]+: 158.1539, found: 158.1538. HPLC: Chiracel-OBH, 
n-heptane/i-PrOH 90:10, 0.5 mL/min, 40 °C, detection at 206 nm. Retention time (min): 9.1 
(minor) and 10.2 (major). 
(S)-N,N-Dimethyl-3-methyl-hexanamide ((S)-15) 
 
In a flame-dried Schlenk tube equipped with septum and magnetic stirring bar, CuBr·SMe2 
(1.64 mg, 0.008 mmol, 5 mol%) and ligand (R,SFe)-L1 (6.15 mg, 0.0096 mmol, 6 mol%) 
were dissolved in 1.6 mL DCM and stirred under nitrogen atmosphere for 20 min. The 
substrate (Z)-13 (0.16 mmol) was added at once. After stirring for 5 min. at RT the reaction 
mixture was cooled down to −78 °C, followed by addition of BF3·Et2O (40 μL, 0.32 mmol) or 
TMSOTf (58 μL, 0.32 mmol). After 20 min., MeMgBr was added by hand in about 1 min. 
After stirring for 18 h, the reaction was quenched with MeOH followed by addition of 
saturated aqueous NH4Cl solution and warming up to RT. The reaction mixture was 
extracted with DCM (10 mL × 3). Combined organic phases were dried over MgSO4, filtered 
and solvents were evaporated on a rotary evaporator. Product (S)-15 was obtained as a 
colorless oil after column chromatography (SiO2, pentane:Et2O = 1:1). 1H NMR (CDCl3, 400 
MHz): δ 3.00 (s, 3H, NCH3), 2.95 (s, 3H, NCH3), 2.29 (dd, J = 14.6, 5.8 Hz, 1H, CHHCO), 2.12 
(dd, J = 14.6, 8.1 Hz, 1H, CHHCO), 2.05-1.97 (m, 1H, CHCH2), 1.43-1.24 (m, 3H, CH2CH3, 
CHHCH2CH3), 1.19-1.10 (m, 1H, CHHCH2CH3), 0.93 (d, J = 6.6 Hz, 3H, CH3CH), 0.89 (t, J = 7.0 
Hz, 3H, CH3CH2). HPLC: Chiracel-OBH, n-heptane/i-PrOH 90:10, 0.5 mL/min, 40 °C, 
detection at 206 nm. Retention time (min): 9.1 (major) and 10.2 (minor). 
TMS-amide complex 
 
TMSOTf (16 μL, 0.088 mmol) was added to a solution of carboxamide 7 (10 mg, 0.088 
mmol) in CD2Cl2 (0.6 mL) in a dry NMR tube at −78 °C under N2 atmosphere, leading to 
instantaneous formation of a new species which was immediately measured by NMR 
spectroscopy at −80 °C. 1H NMR (CD2Cl2, 400 MHz): δ 6.81 (dq, J = 15.5, 6.9 Hz, 1H), 6.41 
(dd, J = 15.5, 1.5 Hz, 1H), 3.37 (s, 3H), 3.25 (s, 3H), 2.05-2.00 (m, 3H), 0.36 (s, 9H). 13C NMR 
(CD2Cl2, 100 MHz): δ 167.2, 152.5, 117.7, 40.4, 38.8, 19.4, 0.2. 29Si NMR (CD2Cl2, 79.5 MHz): 





BF3·Et2O ( 10 μL, 0.08 mmol) was added to a solution of carboxamide 7 (10 mg, 0.088 
mmol) in CD2Cl2 (0.6 mL) in a dry NMR tube at −78 °C under N2 atmosphere, leading to 
instantaneous formation of a new species which was immediately measured by NMR 
spectroscopy at −80 °C. 1H NMR (CD2Cl2, 400 MHz): δ 13.55 (s, 1H), 6.78 (dq, J = 13.6, 6.8 
Hz, 1H), 6.23 (d, J = 15.9, 1H), 3.30 (s, 3H), 3.22 (s, 3H), 2.00 (d, J = 6.8 Hz, 3H) (Major 
species). 13C NMR (CD2Cl2, 100 MHz): δ 169.7, 149.0, 117.6, 41.0, 38.7, 19.9, 14.6 (Major 
species). 11B NMR (CD2Cl2, 100 MHz): δ −0.26, −0.74, −1.22, −1.28. 19F NMR (CD2Cl2, 100 
MHz): δ −146.82 (19F-10B), −146.88 (19F-11B). 
Silyl enolate 
 
In a flame-dried Schlenk tube equipped with septum and magnetic stirring bar, CuBr-
(R,SFe)-L1 complex (5.53 mg, 0.0075 mmol, 5 mol%) and amide 7 (17 mg, 0.15 mmol) were 
dissolved in CD2Cl2 (1.5 mL) and stirred under nitrogen atmosphere. After stirring at room 
temperature for 5 min., the reaction mixture was cooled to −60 °C and TMSOTf (52 μL, 0.30 
mmol) was added. After 15 min., MeMgBr (100 μL, 0.30 mmol, 3.0 M in Et2O) was added. 
After stirring at −60 °C for 18 h, the mixture was transferred to a NMR tube followed by 
measurement at −80 °C. 1H NMR (CD2Cl2, 400 MHz): δ 3.39 (d, J = 9.4 Hz, 1H), 2.42-2.32 (m, 
1H), 2.33 (s, 6H), 0.81 (d, J = 6.7 Hz, 6H), 0.08 (s, 9H). 13C NMR (CD2Cl2, 100 MHz): δ 152.1, 
95.7, 40.4, 25.3, 24.5, −0.4. 29Si NMR (CD2Cl2, 79.5 MHz): δ 19.3. 
Boron enolate 
 
In a flame-dried Schlenk tube equipped with septum and magnetic stirring bar, CuBr-
(R,SFe)-L1 complex (5.53 mg, 0.0075 mmol, 5 mol%) and amide 7 (17 mg, 0.15 mmol) were 
dissolved in CD2Cl2 (1.5 mL) and stirred under nitrogen atmosphere. After stirring at room 
temperature for 5 min., the reaction mixture was cooled to −60 °C and BF3·Et2O (37 μL, 
0.30 mmol) was added. After 15 min., MeMgBr (100 μL, 0.30 mmol, 3.0 M in Et2O) was 
added. After stirring at −60 °C for 18 h, the mixture was transferred to a NMR tube, cooled 
and measured by NMR spectroscopy at −80 °C. 1H NMR (CD2Cl2, 400 MHz): δ 4.78 (d, J = 
10.3 Hz, 1H), 2.66 (s, 6H), 2.50-2.42 (m, 1H), 0.89 (d, J = 6.6 Hz, 6H). 13C NMR (CD2Cl2, 100 
MHz): δ 132.7, 111.6, 44.5, 25.5, 22.7. 
Magnesium enolate 
 
A 3.0 M MeMgBr solution in Et2O (67 μL, 0.2 mmol) was added to a solution of amide 7 (12 
mg, 0.10 mmol) in CD2Cl2 (0.6 mL) in a dry NMR tube under N2 atmosphere. After 18 h the 





(d, J = 8.7 Hz, 1H), 2.41 (s, 6H), 2.38-2.27 (m, 1H), 0.84 (d, J = 6.6 Hz, 6H). 13C NMR (CD2Cl2, 
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